Poplar Therapeutics
Poplar Therapeutics is a biotechnology company developing gene therapies for rare genetic diseases, with a focus on neurological and metabolic disorders.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $50M
About
Poplar Therapeutics is a biotechnology company developing gene therapies for rare genetic diseases, with a focus on neurological and metabolic disorders.
Gene TherapyRare DiseaseNeuroscience
Funding History
1Total raised:$50M
Series A$50M